Abingworth LLP 13D and 13G filings for Reneo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-20 4:07 pm Purchase |
2021-04-13 | 13D | Reneo Pharmaceuticals, Inc. RPHM |
Abingworth LLP | 185,823 7.700% |
185,823 (New Position) |
Filing |